Latest News - Acquisitions and Mergers

Monday, June 04, 2018

Gryphon Investors Makes Majority Investment in Water's Edge Dermatology

Gryphon Investors has made a majority investment in Water’s Edge Dermatology. Terms of the transaction were not disclosed. Gryphon Investors is a San Francisco-based middle market privat…

Read the full story

Friday, March 30, 2018

Escalier Biosciences Closes Financing, Focuses on Psoriasis

Escalier Biosciences BV, a privately held biopharmaceutical company, this month closed $19 million Series B financing. The round was led by Forbion with existing investors New Science Ventur…

Read the full story

Tuesday, November 14, 2017

Obagi Eyes the Future Under New Ownership

The sale of Obagi Medical Products to the Haitong International Zhonghua Finance Acquisition Fund I, L.P. and limited partners China Regenerative Medicine International (CRMI) Ltd. is now complete. …

Read the full story

Wednesday, November 08, 2017

Novan Plans to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution

Novan, Inc., has agreed in principle to a business structure that would enable further development and advancement of SB204 for the treatment of acne vulgaris via third party financing and third party…

Read the full story

Wednesday, August 02, 2017

Modernizing Medicine To Add More Than 800 Jobs in Expansion

Modernizing Medicine will expand operations and add a total of 838 jobs by 2022. The expansion, to be implemented in the historic Boca Raton Innovation Center (BRIC) in Palm Beach County will result i…

Read the full story

Tuesday, July 25, 2017

Histogen’s Growth Factor Technology Now Part of Allergan's Skin Care Line

Histogen’s growth factor technology will be marketed as part of Allergan's skin care line within its recently acquired Regenica® Advanced Rejuvenation System. The Regenica line is bas…

Read the full story

Tuesday, July 18, 2017

Valeant to Sell Obagi Medical Products Business for $190 M

Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acqui…

Read the full story

Monday, July 17, 2017

Syneron Candela Completes Transaction with Funds Advised by Apax Partners; Becomes a Private Company

Syneron Medical Ltd. announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners for $11.00 per share in cash in a transaction valued at approximately $400…

Read the full story

Friday, April 28, 2017

Allergan Officially Adds Coolsculpting to Portfolio

It’s a done deal. Allergan now owns ZELTIQ® Aesthetics. Allergan acquired ZELTIQ® Aesthetics for approximately $2.4 billion in cash. ZELTIQ® stockholders approved the transa…

Read the full story

Thursday, April 06, 2017

Business News: Allergan and ZELTIQ Announce Expiration of HSR Waiting Period for Pending Transaction

Allergan is now one step closer to officially acquiring Zeltiq. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") has expired with res…

Read the full story

Monday, April 03, 2017

Apax Partners To Acquire Syneron for Close to $400 million

An affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron Candela for $11.00 per share in cash in a transaction valued at approximately $397 m…

Read the full story

Monday, March 06, 2017

Pierre Fabre and Hill Dermaceuticals Partner in Commercial Partnership for TOLAK for AKs

Pierre Fabre Dermo-Cosmetique and Hill Dermaceuticals, Inc. have entered into a strategic commercial partnership for TOLAK, a patented prescription dermatologic drug, indicated for the topical treatme…

Read the full story

Tuesday, February 21, 2017

CareCredit to Acquire CitiHealth Card Portfolio

CareCredit has signed an agreement with Citibank, N.A. to acquire the Citi Health Card portfolio, further expanding its healthcare acceptance network in the United States.  The portfolio …

Read the full story

Tuesday, February 14, 2017

Rumor Has It Syneron Is Next In Week of Surprising Aquisitions

Hot off the heels of Allergan’s acquisition of Zeltiq and Hologic Inc,’s surprising purchase of Cynosure Inc., media reports are now swirling that British private equity fund Apax Partners…

Read the full story

Tuesday, February 14, 2017

Hologic to Acquire Cynosure

Hologic, Inc.  and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an eq…

Read the full story
Load More